Combining increased GLP-1 with a natural DPP4 inhibitor may help the effect to last a little longer
However, the use of semaglutide in this population should be carefully evaluated on a case-by-case basis, taking into account factors such as the type of surgery, time since the procedure, and overall health status
they offer a path towards improved quality of life, potentially reducing reliance on medication over time and preventing long-term complications
Results: Across completed head-to-head randomized trials, tirzepatide consistently achieved greater reductions in body weight, and HbA1c than semaglutide in individuals with obesity or T2DM
The Bottom Line It can be a great option, but you need to do thorough research to understand the pricing they offer
More research is still needed to understand the benefits of semaglutide on heart risks for those without diabetes